The DOI matches its Crossref record.
Adrenal Neoplasms: CT-guided Radiofrequency Ablation—Preliminary Results
Abstract
PURPOSE: To evaluate initial experience with radiofrequency (RF) ablation of adrenal neoplasms. MATERIALS AND METHODS: Thirteen adrenal masses in 12 patients (bilateral metastases in one patient) were treated with computed tomography (CT)-guided percutaneous RF ablation. Eleven adrenal lesions were metastases (five from lung cancer, four from renal cell carcinoma, and two from melanoma); one lesion was a pheochromocytoma and one was an aldosteronoma. There were 10 men and two women (average age, 58 years; range, 40-77 years) in the study; average adrenal mass diameter was 3.9 cm (range, 1-8 cm). Average number of RF applications per adrenal mass was 2.7 (range, 1-5 applications); average time per application was 7.8 minutes (range, 4-13 minutes). An internally cooled single electrode was used in five sessions; an internally cooled cluster electrode was used in eight sessions. RESULTS: Average follow-up was 11.2 months (range, 1-46 months). Eleven of 13 lesions were treated successfully with RF ablation after one session. Successful treatment was defined as lack of enhancement of the treated region on follow-up CT images and resolution of the biochemical abnormality in two patients. In two patients with large adrenal lesions (4 and 8 cm in diameter), enhancement of residual tissue was observed after one treatment session; this finding was indicative of residual tumor. One patient with thrombocytopenia that resulted from chemotherapy had a small hematoma, but no transfusion was required. No patient developed hypertension during the RF application. No patient with metastases had recurrent tumor at the treated site, and this lack of recurrence indicated effective local control; 11 patients had progression of metastatic disease at extraadrenal sites. CONCLUSION: Preliminary data suggest that CT-guided RF ablation is an effective technique for local control of adrenal neoplasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Lenders, J. W., Eisenhofer, G., Mannelli, M., & Pacak, K. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67139-5 · Cited by 1,524
Microwave Ablation: Principles and Applications
Simon, C. J., Dupuy, D. E., & Mayo-Smith, W. W. (2005) · RadioGraphics · doi:10.1148/rg.25si055501 · Cited by 1,023
Self-citationIncidental Adrenal Lesions: Principles, Techniques, and Algorithms for Imaging Characterization
Boland, G. W. L., Blake, M. A., Hahn, P. F., & Mayo-Smith, W. W. (2008) · Radiology · doi:10.1148/radiol.2493070976 · Cited by 381
Self-citationKiseljak-Vassiliades, K., Bancos, I., Hamrahian, A., Habra, M. A., Vaidya, A., Levine, A. C., & Else, T. (2020) · Endocrine Practice · doi:10.4158/dscr-2020-0567 · Cited by 66
“For patients with unresectable recurrences or metastatic lesions or for those who opt against surgery, local therapies such as radiofrequency ablation, percutaneous laser ablation, cryoablation, microwave ablation, and transcatheter arterial chemoembolization approaches may provide local control (68,69).”
Background
Metadata
- Authors
- Mayo-Smith, W. W., & Dupuy, D. E.
- Venue
- Radiology
- Published
- 2004-04
- Volume
- 231
- Issue
- 1
- Pages
- 225-230
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2077889045
- Cited by
- 183
- References
- 0
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adrenal Neoplasms: CT-guided Radiofrequency Ablation—Preliminary Results. https://app.cochat.ai/papers/10.1148/radiol.2311031007
- The paper
- Mayo-Smith, W. W., & Dupuy, D. E. (2004). Adrenal Neoplasms: CT-guided Radiofrequency Ablation—Preliminary Results. Radiology. https://doi.org/10.1148/radiol.2311031007
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.